IL6 and neoplasm: In addition to driving inappropriate proliferation and angiogenesis, IL6 sustains JAK/STAT3 signaling and impairs the local immune function via prevention of dendritic cell maturation, recruitment, and expansion of myeloid-derived suppressor cells and tumor-associated neutrophils and upregulation of immune checkpoint inhibitors, such as PD-L1 [40].